Inflammation in sickle cell disease
- 28 March 2018
- journal article
- research article
- Published by IOS Press in Clinical Hemorheology and Microcirculation
- Vol. 68 (2-3), 263-299
- https://doi.org/10.3233/CH-189012
Abstract
The primary β-globin gene mutation that causes sickle cell disease (SCD) has significant pathophysiological consequences that result in hemolytic events and the induction of the inflammatory processes that ultimately lead to vaso-occlusion. In additiKeywords
This publication has 367 references indexed in Scilit:
- A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodesHaematologica, 2013
- The Haptoglobin-CD163-Heme Oxygenase-1 Pathway for Hemoglobin ScavengingOxidative Medicine and Cellular Longevity, 2013
- Plasma thrombospondin‐1 is increased during acute sickle cell vaso‐occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic ratesAmerican Journal of Hematology, 2011
- Laboratory and echocardiography markers in sickle cell patients with leg ulcersAmerican Journal of Hematology, 2011
- Leg ulcers in sickle cell diseaseAmerican Journal of Hematology, 2010
- Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell diseaseJournal of Molecular Medicine, 2010
- Plasma interleukin-1β concentration is associated with stroke in sickle cell diseaseCytokine, 2010
- Inflammatory cytokines in vascular dysfunction and vascular diseaseBiochemical Pharmacology, 2009
- Redox-dependent impairment of vascular function in sickle cell diseaseFree Radical Biology & Medicine, 2007
- Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypesBlood Reviews, 2007